Rapid Point-of-care Bacteriuria and Microbial Susceptibility for Women With Suspected Uncomplicated Urinary Tract Infections: Diagnostic Accuracy in General Practice.

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorWuerzburg University Hospital

About this trial

In this study, adult women presenting at their general practitioner with a likely bladder infection (with symptoms like a burning sensation when urinating, pain in the lower abdomen, and frequent or urgent need to urinate) will be invited. After informed consent, women provide a urine sample, which is tested using a new system called the PA-100-AST (from the manufacturer Sysmex). This point-of-care test showed first evidence to be able to quickly detect the presence of bacteria commonly responsible for bladder infections. If bacteria are found, the test also checks which antibiotics may work best to treat the infection. Additionally, a sample of the urine is sent to a lab for a traditional culture test, which is considered the most accurate method. The goal of this study is to compare the accuracy of the PA-100-AST system to the lab-based test to see how well it works in general practice.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Female sex

Age 18 or older

Clinically suspected UTI according to the general practitioner

Disqualifiers

Urinary catheter

Severe urinary tract abnormality (such as cancer or strictures)

Immunosuppression (such as chronic immunosuppressant use or AIDS)

Dementia or any other condition (including insufficient knowledge of the German language) that could affect informed consent

Trial population

Consecutively enrolled adult non-pregnant women with a suspected uncomplicated UTI (uncomplicated is defined according to German guidelines/usual care as having no symptoms or signs of systemic illness, such as fever).

Trial design

Design model

Cohort

Time perspective

Cross-sectional

Treatments tested in this trial

Not listed

Trial groups

200 Participants
are grouped into 1 trial group
Group A: Women with suspected UTI

Trial outcomes

Primary outcomes

1

Sensitivity

Sensitivity of point-of-care urinalysis through Sysmex PA-100-AST vs. laboratory-based urine culture (gold standard) of point-of-care urinalysis through Sysmex PA-100-AST vs. laboratory-based urine culture (gold standard)

Time frame
On the 1 day of inclusion
2

Specificity

Specificity of point-of-care urinalysis through Sysmex PA-100-AST vs. laboratory-based urine culture (gold standard) of point-of-care urinalysis through Sysmex PA-100-AST vs. laboratory-based urine culture (gold standard)

Time frame
On the 1 day of inclusion
3

Positive predictive value

Positive predictive value of point-of-care urinalysis through Sysmex PA-100-AST vs. laboratory-based urine culture (gold standard) of point-of-care urinalysis through Sysmex PA-100-AST vs. laboratory-based urine culture (gold standard)

Time frame
On the 1 day of inclusion
4

Negative predictive value

Negative predictive value of point-of-care urinalysis through Sysmex PA-100-AST vs. laboratory-based urine culture (gold standard) of point-of-care urinalysis through Sysmex PA-100-AST vs. laboratory-based urine culture (gold standard)

Time frame
On the 1 day of inclusion

Secondary outcomes

Other outcomes

1

Agreement of test results for antibiotic susceptibility

Agreement of point-of-care based with laboratory-based antibiotic susceptibility test results measured through kappa coefficients

Time frame
On the 1 day of inclusion

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Wuerzburg University Hospital

Lead sponsor

Jena University Hospital

Collaborator